<html xmlns="http://www.w3.org/1999/xhtml"><body><table class="table"><caption /><tr><th class="cell">Study </th><th class="cell">Sample </th><th class="cell">Main results </th></tr><tr><td class="cell">Ardouin et al. (2006)</td><td class="cell">7 PD patients with PG</td><td class="cell">After STN DBS PG resolved, possibly due to reduction in dopaminergic medication</td></tr><tr><td class="cell">Bandini et al. (2007)</td><td class="cell">2 PD patients with PG</td><td class="cell">After STN DBS and reduction in dopaminergic medication PG resolved</td></tr><tr><td class="cell">Castrioto et al. (2014)</td><td class="cell">20 PD patients after STN DBS</td><td class="cell">IGT score signifcantly improved after STN DBS and reduction in dopaminergic medication</td></tr><tr><td class="cell">Contarino et al. (2007)</td><td class="cell">11 PD patients after STN DBS</td><td class="cell">Transient ICD after STN DBS surgery</td></tr><tr><td class="cell">Dodd et al. (2005)</td><td class="cell">11 PD patients with PG</td><td class="cell">Strong association with DA, PG did not develop under L-dopa monotherapy, but L-dopa might</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">be contributory</td></tr><tr><td class="cell">Funkiewiez et al. (2003)</td><td class="cell">50 PD patients after STN DBS</td><td class="cell">Transient ICDs after STN DBS surgery</td></tr><tr><td class="cell">Frank et al. (2007)</td><td class="cell">32 PD patients</td><td class="cell">Higher impulsivity on STN DBS</td></tr><tr><td class="cell">Gallagher et al. (2007)</td><td class="cell">177 PD patients with PG</td><td class="cell">Strongest association with DA; no clear difference between each DA; L-dopa the most frequently</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">co-prescribed medication</td></tr><tr><td class="cell">â‚¬</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Halbig et al. (2009)</td><td class="cell">53 PD patients</td><td class="cell">Higher BIS scores in PD patients with STN DBS; ICD more frequent in patients after STN DBS</td></tr><tr><td class="cell">Voon et al. (2006)</td><td class="cell">297 patients with PD</td><td class="cell">PG more frequent in patients with DA monotherapy and DA + L-dopa then L-dopa monotherapy;</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">no association to dose</td></tr><tr><td class="cell">Weintraub et al. (2006)</td><td class="cell">272 patients with PD</td><td class="cell">No difference between each DA; higher LEDD associated with ICDs</td></tr><tr><td class="cell">Weintraub et al. (2010)</td><td class="cell">3090 patients with PD</td><td class="cell">Highest ICD frequency in patients under combined DA and L-dopa therapy; strong association</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">with DA; no difference between DA medications</td></tr></table></body></html>